VICTORIA, BC – Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX), a clinical-stage biotechnology company, announced that it has priced its previously announced overnight marketed public offering (the “Offering”)… Read More
Implementing meaningful and effective changes to the research approvals processes across British Columbia’s health authorities starts with a thorough and verified understanding of the current state of those processes. Understanding… Read More
Antibody-drug conjugates are gaining traction as an alternative or complementary therapy for different types of cancers Contest opened March 11, 2024; five winners will spend three weeks in Uppsala, Sweden… Read More
OTTAWA, ON – The University of Ottawa (uOttawa) has partnered with The Ottawa Hospital’s Biotherapeutics Manufacturing Centre (OHRI) and the Canadian Alliance for Skills and Training in Life Sciences (CASTL) to deliver… Read More
Applications are now open to become one of 13 selected youth changemakers in Canada given the opportunity to have their sustainability efforts amplified on a national and global scale, participate… Read More
